Table 1.
Patient Characteristics and Comorbiditiesa
| Variable | Uncolonized (n = 204) | Toxigenic C. difficile (n = 40) | Nontoxigenic C. difficile (n = 15) |
|---|---|---|---|
| Age, y, mean (SD) | 58 (14.4) | 56 (16.3) | 52 (16.1) |
| White race | 130 (63.7%) | 29 (72.5%) | 13 (86.7%) |
| Female sex | 96 (47.0%) | 22 (55.0%) | 9 (60.0%) |
| Type of service | |||
| Medicine | 180 (88.2%) | 33 (82.5%) | 13 (86.7%) |
| Surgery | 24 (12.8%) | 7 (17.5%) | 2 (13.3%) |
| Admitted from | |||
| Home | 156 (76.5%) | 27 (67.5%) | 11 (73.3%) |
| Other healthcare facility | 48 (23.5%) | 13 (32.5%) | 4 (26.7%) |
| Admission reason | |||
| Infection | 60 (29.4%) | 10 (25.0%) | 5 (33.3%) |
| Chronic condition | 75 (36.8%) | 17 (42.5%) | 6 (40.0%) |
| Elective surgery | 10 (4.9%) | 0 | 1 (6.7%) |
| New medical/surgical problem | 59 (28.9%) | 13 (32.5%) | 3 (20.0%) |
| Comorbidities | |||
| Diabetes mellitus | 76 (37.3%) | 12 (30.0%) | 3 (20.0%) |
| Congestive heart failure | 37 (18.1%) | 9 (22.5%) | 2 (13.3%) |
| Liver disease | 18 (8.8%) | 5 (12.5%) | 4 (26.7%) |
| Chronic kidney disease | 34 (16.7%) | 9 (22.5%) | 3 (20.0)% |
| Chronic lung disease | 46 (22.5%) | 12 (30.0%) | 4 (26.7%) |
| HIV | 4 (2.0%) | 0 | 0 |
| Solid organ transplant | 14 (6.9%) | 2 (5.0%) | 3 (20.0%) |
| Stem cell transplant | 1 (0.5%) | 0 | 0 |
| Solid malignancy | 10 (4.9%) | 4 (10.0%) | 1 (6.7%) |
| Hematological malignancy | 3 (1.5%) | 1 (2.5%) | 2 (13.3%) |
| Inflammatory bowel disease | 4 (2.0%) | 1 (2.5%) | 0 |
| History of CDI | 4 (2.0%) | 1 (2.5%) | 0 |
| Developed CDI while hospitalized or during follow-up period | 2 (1.0%) | 1 (2.5%) | 0 |
Data are presented as No. (%) unless otherwise specified.
Abbreviations: C. difficile, Clostridium difficile; CDI, Clostridium difficile infection; HIV, human immunodeficiency virus; SD, standard deviation.
a There were no statistically significant differences between groups.